Prevalence and Treatment of Familial Hypercholesterolemia According to the Dutch Lipid Clinic Network Score (DLCNS): a Retrospective,Single Centered |
| |
| Institution: | 1. Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia (UBC), Vancouver, BC, Canada;2. Centre for Heart & Lung Innovation, St. Paul''s Hospital, Vancouver, Canada;3. Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO;4. National Center for Advancing Translational Sciences, NIH, Rockville, MD;5. Biomedical Research Centre, UBC, Vancouver, Canada;6. Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK;7. Department of Medicine, UBC, Vancouver, Canada;8. Department of Pediatrics, University of British Columbia (UBC), BC Children''s Hospital Research Institute, Vancouver, Canada;9. Department of Neurology, University of Missouri, Columbia, MO;10. Department of Bioengineering, Faculty of Medicine, University of Missouri, Columbia, MO;11. Department of Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO;1. Surgical Intensive Care Unit (SICU), Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China;2. Department of Gastroenterology, Clinical Medical College, Yangzhou University, Yangzhou, China;3. Department of Intensive Care Unit, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China;4. Institute of Medical Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom;5. EFS, Univ Brest, Inserm, UMR 1078, GGB, Brest, France;1. Department of Molecular Medicine, Lipid Clinic and Atherosclerosis Prevention Centre, ‘Umberto I’ Hospital - ‘Sapienza’ University of Rome, Rome, Italy;2. Department of Internal Medicine - Polyclinic Hospital San Martino, University of Genoa, Genoa, Italy;3. Department of Food and Drug, University of Parma, Parma, Italy;4. Endocrinology and Metabolic Diseases, Civile Maggiore Hospital of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy;5. Immunohematology and Transfusion Medicine, ASL3, Pistoia, Italy;6. Department of Internal Medicine, University of Genoa, Italy;7. Department of Life Sciences, University of Parma, Italy;8. Inserm UMR_S1140 “Innovative Therapies in Haemostasis” Faculté de Pharmacie de Paris, Université Paris Descartes, Paris, France;9. French Institute of Health and Medical Research (Inserm), France;10. Department of Medicine, Northwest Lipid Research Laboratories, University of Washington, Seattle, WA, USA;11. School of Medicine, Faculty of Health and Medical Sciences - Cardiometabolic Service, Department of Cardiology, Royal Perth Hospital University of Western Australia, Perth, Western Australia, Australia;1. Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute, Québec, Canada;2. Department of Medicine, Division of Endocrinology, Université de Montreal, Québec, Canada;3. Department of Medicine, Divisions of Experimental Medicine and Medical Biochemistry, McGill University, Québec, Canada;4. Genetic Molecular Epidemiology Lab, Population Health Research Institute, Ontario, Canada |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
